Tag Global

Prach Kaushik, Founder and Director of Vyomini Social Enterprise, Honored with the prestigious Rex Karmaveer Global Fellowship & Karamveer Chakra Award for her work in promoting sustainable sanitation, hygiene practices, and entrepreneurship at a vibrant ceremony held at The Shri Ram Millennium School in Noida. Recognized for her pioneering contributions to menstrual health and hygiene management, Prachi’s efforts have touched the lives of millions, redefining social impact and empowering women across India.

The award is instituted by iCONGO in partnership with United Nations (UN). The Rex Karmaveer Chakra Awards celebrate real-life heroes who embody the spirit of ‘Be the Change.’ These awards spotlight individuals who take bold, innovative paths to inspire and bring about meaningful change.

From breaking societal norms by rejecting an early marriage at 16 to founding Vyomini, Prachi’s life journey is a testament to resilience, courage, and vision. Through Vyomini, she has trained over 5,000 women under various entrepreneurship development programs and created sustainable menstrual hygiene solutions that have reached over 20 lakh women through awareness campaigns and workshops across 20 states.”

Under her leadership, Vyomini has achieved remarkable milestones, including:

• Establishing 10 incubation centers for rural entrepreneurs.
• Training women in manufacturing essential hygiene products like sanitary pads, vending machines, and incinerators.
• Conducting over 550 workshops for marginalized communities, including youth, released prisoners, and transgender individuals.
• Transforming menstruation into an opportunity for entrepreneurship by creating local ecosystems for production and distribution.

Speaking at the occasion, Prachi Kaushik, Founder and Director of Vyomini Social Enterprise, said,  “Menstrual health isn’t just about hygiene—it’s about dignity, empowerment, and human rights, The journey began with a single step, but today, Vyomini stands as a movement to advocate for women-led development. I envision a future where every woman has access to not only safe hygiene practices but also the tools to build a better life for herself and her community.”

She has revolutionized menstrual hygiene through innovative approaches and has also reached the last mile. With Project Naritav, she helps women make their own pads. Prachi believes it’s not just about donating pads, but also about investing in pads. This unique concept enables women to locally produce pads while generating income.”

Prachi envisions a world that transcends caste, religion, and gender barriers, focusing solely on equality and humanity. Her goal is to establish one incubation center in every district of India, making it easier for women to enhance their skills and build entrepreneurial careers.

Reflecting on her journey, she adds, “I want to leave behind a legacy of equal opportunities. Every woman, regardless of her background, deserves a chance to shine. My work isn’t just about building businesses—it’s about building lives.”

Her transformational contributions to menstrual health, combined with her tireless advocacy for women’s rights, have positioned her as a thought leader on development issues.

Prachi Kaushik’s recognition at the Rex Karmaveer Chakra Awards is a moment of pride not only for her but for all who believe in the power of grassroots leadership to drive systemic change.

New Delhi, 19th November 2024 – Shiv Nadar University, Delhi-NCR, and Atal Incubation Center at Shiv Nadar University, in partnership with the Global Trade and Innovation Policy Alliance (GTIPA) and the Institute for Competitiveness, hosted the GTIPA Summit 2024 from 14th – 15th November in Delhi. This prestigious summit, held for the first time in India, gathered global policymakers, industry leaders, and academic experts to foster dialogue on global trade, innovation policy and strategies for sustainable economic growth.

The two-day summit, themed “India: The Innovation Hub for Tomorrow,” is spotlighting leaders from over 35 countries, including diplomats, bureaucrats, industry CEOs, startup founders, and investors. Day 1 of the summit brought together leaders from various regions, including the US, UK, and Asia Pacific. It featured an impressive lineup of speakers, including academicians, leading researchers, government officials, and regulatory experts. Notable highlights included panels on the future of global trade and innovation, providing attendees with practical insights into crucial topics such as regulatory frameworks, innovation policy, and emerging technology trends.

At a welcome dinner held prior to the conference, Mr. Abhay Karandikar, Secretary of the Department of Science and Technology (DST), Ministry of Science and Technology, Government of India, shared valuable insights into the India’s rapidly expanding innovation ecosystem. He emphasized the rise of over 10,000 deep-tech startups across fields such as artificial intelligence, clean energy, and biotechnology, many of which are translating academic research into commercial success. Mr. Karandikar highlighted the Ministry’s active support, noting the provision of funding to approximately 700 startups in these critical sectors. Looking ahead, he expressed optimism that increased private sector investment in research and development would further drive India’s ascent as a global innovation powerhouse over the next decade.

In his keynote address, Montek Singh Ahluwalia, former Deputy Chairman of the Planning Commission of India, emphasized, “Innovation is driven by creative destruction—the need to replace outdated systems with more efficient ones. India’s strength in software and emerging sectors like drones offers a unique opportunity to build globally competitive products. However, for India to lead, we must foster a more open trade regime that enables startups to thrive, focusing not just on growth but on profitability and long-term sustainability. Institutions like Shiv Nadar University play a crucial role in nurturing talent and fostering the kind of innovation that will shape the industries of the future.”

Dr. Rajat Kathuria, Dean, School of Humanities and Social Sciences, Shiv Nadar University, Delhi-NCR, mentioned, “India stands at the confluence of technological progress and societal transformation, driving innovation not only in advanced technologies but in tackling global challenges like climate change, healthcare, and economic equity. At Shiv Nadar University, we believe sustainable innovation flourishes where science, technology, policy, and humanities intersect. True innovation shapes a better tomorrow by addressing today’s challenges with inclusivity and sustainability. Platforms like the GTIPA Summit are crucial for fostering collaboration and amplifying diverse voices to solidify India’s leadership in innovation.”

The summit featured influential voices such as Mr. Stephen Ezell Vice President, Global Innovation Policy, The Information Technology & Innovation Foundation, John Cabeca, U.S. Intellectual Property Counselor for South Asia, U.S. Patent and Trademark Office (USPTO), American Embassy – New Delhi, Mr Richard Dasher, Director, US-ATMC, Stanford University, Dr Rajat Kathuria, Dean, School of Humanities and Social Sciences & Professor, Department of Economics, Shiv Nadar University and Dr. Sheeba Khan, CEO, Shiv Nadar Atal Incubation Centre (AIC).

Key discussions covered India’s growing role in global semiconductor supply chains, regional innovation ecosystems driving national growth, and regulatory frameworks in life sciences and healthcare to accelerate sector advancements.

On Day 2 of the summit, delegates visited the Shiv Nadar University, Delhi-NCR campus for an immersive experience. This included guided tours of the university’s state-of-the-art Search and Innovation Labs, offering a glimpse into groundbreaking research projects. Additionally, a startup exhibition was organized, showcasing innovative ventures incubated at the Shiv Nadar Atal Incubation Centre (AIC). The exhibition highlighted the creativity, market-ready solutions, and entrepreneurial talent emerging from India’s vibrant startup ecosystem, further emphasizing the nation’s role as a global innovation leader.

Since 2021, Shiv Nadar AIC has been a member of the GTIPA alliance, which hosts its annual summit in different countries each year. The 2024 summit marks the first time this event is being held in India, a significant milestone for both GTIPA and Shiv Nadar University. As GTIPA 2024 progresses, attendees look forward to further insights and strategies to enhance India’s role in the global innovation landscape.

NOIDA, India, Nov 16, 2024—HCLTech, a leading global technology company, today announced a new node in its global AI & Cloud Native Lab partner network through a collaboration with long-time partner ServiceNow.

The companies today inaugurated a dedicated facility in HCLTech’s Noida campus, where customers can pilot, navigate and scale innovative solutions to address industry-specific challenges. The same experiences will also be accessible in the HCLTech AI & Cloud Native Lab in London.

“Establishing the AI Lab in partnership with ServiceNow is a testament to our 12-year partnership and commitment to delivering value to our clients, allowing them to test and learn in a simulated environment,” said Jagadeshwar Gattu, President, Digital Foundation Services at HCLTech. “The early adoption and scaling of GenAI capabilities will help businesses unlock new efficiencies and enhance continuous service delivery to drive business transformation.”

“Our expanded partnership with HCLTech will help us to accelerate AI adoption for more customers in the UK and India,” said Michael Park, SVP and Global Head of AI GTM at ServiceNow. “These Labs will help empower customers to take control of their AI investments and unlock new levels of productivity and profitability across the enterprise.”

The Labs leverage HCLTech’s industry-leading and proven methodologies for clients to navigate GenAI and agentic AI journeys with ServiceNow, driving efficiencies in the areas of ESM (enterprise service management) and industry verticals.

In addition to proprietary assets including HCLTech AI Force and Enterprise AI Foundry, the Labs will include assets built with accelerators and frameworks modeled for the ServiceNow platform. Those include ValueNow, to assess GenAI readiness; ComplyNow, to assess and identify key security and risk areas; and AchieveNow, to help customers optimize GenAI value and outcomes.

Vadodara, 14 November 2024 – In a significant move that underscores India’s growing presence in the global frozen food market, Wardwizard Foods and Beverages Limited under has successfully shipped a diverse product range of under the brand QuikShef to Canada, USA, and UAE. This shipment to USA and UAE includes popular items such as Ready to Eat Indian Meals, such as Palak Paneer, Dal Makhni, Kadhi Pakoda, including customized products such as Gujarati Dal and Amritsari Chole. Additionally, the shipment to Canada includes frozen foods with a distinctive Indian flair, such as Jain Pizza, Veggie Delight Pizza, Tandoori Paneer Pizza, along with a variety of savory snacks like Burger Patties and Cheese Corn Samosas, catering to diverse palates and preferences.

Reflecting on this achievement, Mrs. Sheetal Bhalerao, Chairperson and Managing Director, Wardwizard Foods and Beverages Ltd, said, “Our journey towards taking authentic Indian flavors to the global market is gaining momentum with each new milestone. This shipment is a step towards sharing the richness of Indian cuisine with an international audience. We are pleased to see QuikShef products reach new regions, from traditional Indian meals to fusion items like our pizzas, resonating with consumers abroad. Looking ahead, our goal is to enter additional global markets, offering a versatile range of flavors that embody the richness of Indian cuisine and cater to diverse tastes worldwide.”

The consignment for Canada, shipped to Ontario and Toronto, consists of 1320 boxes featuring high-quality vegetarian options, tailored to cater to the evolving tastes of international consumers. This strategic venture not only highlights the increasing demand for Indian cuisine abroad but also positions Wardwizard as a key player in the competitive frozen food sector.

In addition to the recent shipment to Canada, Wardwizard Foods and Beverages Limited under the brand name ‘QuikShef’ recently exported products to the USA, specifically to New Jersey. The retail product line is available in the ‘Indian Grocers’ retail chain, further expanding the company’s reach in the North American market.

Moreover, in May 2024, the company shipped 1300 cartons of Ready-to-Eat (RTE) products to Dubai, UAE, and followed this with a June 2024 shipment of 500 cartons to New Jersey, USA. These achievements underline the company’s strategic focus on expanding its global presence, particularly in regions with a strong demand for authentic Indian cuisine.

As consumers worldwide embrace convenience without compromising on taste or nutrition, Wardwizard is poised to capitalize on this trend by providing authentic Indian flavors that resonate with diverse palates. The shipment is a testament to India’s potential as a hub for premium frozen food production and signifies enhanced opportunities for local manufacturers in the international arena.

Wardwizard Foods and Beverages Limited remains dedicated to delivering innovative food solutions while contributing to India’s economic growth through export initiatives. This latest development marks another milestone in their journey towards becoming a recognized leader in the global frozen food market.

Chennai, 11 November 2024: The 7th edition of the Apollo Cancer Conclave, organized by Apollo Cancer Centers ,Mumbai was attended by over 2,000 Oncologist with over 400 faculty from leading national and international cancer care experts and researchers. The event focused on discussing the latest advances and innovations in cancer care, navigating the evolving landscape from contemporary treatments to precision oncology.

Held from November 8th to 10th, the conclave provided a dynamic platform for healthcare professionals to engage in panel discussions, workshops, and research presentations. The key note and the sessions offered invaluable insights into both established and emerging cancer care treatments and management strategies.

With seven organ-specific scientific tracks, more than 100 sessions, and numerous interactive discussions, the Apollo Cancer Conclave has firmly established itself as the cornerstone event in oncology. It is now a key fixture on the healthcare calendar for oncology specialists dedicated to combating cancer more effectively and empathetically.

Dr. Elisabete Weiderpass, Director of the International Agency for Research on Cancer (IARC) at the World Health Organization, remarked, “IARC’s 2022 estimates show that the global cancer burden is projected to rise from 20 million new cases in 2022 to 35 million by 2050, primarily impacting low- and middle-income countries. In India, the cancer burden is expected to rise from 1.41 million new cases in 2022 to 2.69 million in 2050. With this alarming prediction, prevention has become the key response to the cancer epidemic. Initiatives like the Apollo Cancer Conclave 2024 offer an invaluable platform to raise awareness among local experts. At IARC, our vision is a world where fewer people develop cancer, and this requires proactive, evidence-based strategies in prevention and early detection. The Conclave has been a remarkable opportunity to share these strategies and strengthen our collective mission.”

Ms. Preetha Reddy, Executive Vice Chairperson of Apollo Hospitals Enterprise Ltd, stated, “Apollo Hospitals was founded with a vision to deliver healthcare of global standards. We continue that legacy by revolutionizing cancer care through new benchmarks, advanced technologies, and innovative treatments, ensuring better outcomes for a wider audience. With over 390 oncologists across 22 Apollo Cancer Centres, we deliver compassionate, patient-centric care, benchmarked against the best globally. The inauguration of the Apollo Cancer Conclave highlights our commitment to bringing the highest standards of healthcare to the people of India and the world.”

Mr. Dinesh Madhavan, President of Group Oncology & International at Apollo Hospitals Enterprise Ltd, said, “As we delve deeper into the evolving field of oncology, it’s critical to recognize the groundbreaking innovations emerging worldwide. Significant advancements in early cancer detection are on the horizon, and with our well-trained clinicians and cutting-edge technologies, we continue to reshape the oncology landscape. Today, cancer care means providing comprehensive, 360-degree support. By keeping pace with technological advancements in cancer management and treatment, Apollo Cancer Centres remains at the forefront of this transformative journey, serving 3.5 billion people across 147 countries.”

Dr. Anil D’cruz, Director of Oncology Services at Apollo Hospitals Navi Mumbai, commented, “The Apollo Cancer Conclave has become a highly anticipated event within the global oncology community, bringing together thought leaders, practitioners, and researchers dedicated to transforming cancer care. Our goal is to inspire, challenge, and collectively advance cancer treatment through knowledge-sharing and collaboration. This year’s focus on precision oncology underscores the shift toward more tailored, patient-centric approaches to cancer treatment, ultimately improving the quality of life for every patient battling cancer.”

The Conclave featured a wide range of sessions covering various areas of oncology, including breast, gynecology, gastrointestinal, head and neck, uro-oncology, and hematolymphoid cancers. With keynote addresses, interactive panels, and real-time case discussions, the event highlighted the transformative potential of technology and precision medicine in cancer care, emphasizing patient-centric innovations.

One of the Conclave’s major announcements was the introduction of Apollo’s new Breast Cancer Care guidelines, which are set to redefine how breast cancer is managed across India.

The Apollo Cancer Conclave 2024 set the stage for continued advancements in cancer care, establishing new benchmarks in precision oncology, robotics, AI-based patient care, and clinical collaboration. This year’s event exemplified Apollo’s commitment to pushing the boundaries of oncology and reinforced its role as a global leader in transforming cancer care.

New Delhi, India – November 4, 2024 – Humaira Mushtaq, India’s first and only female racer to compete in the prestigious British Endurance Championship, continues to shatter stereotypes and break barriers in the male-dominated world of motorsports.

Born and raised in Kashmir, Humaira’s remarkable journey is an inspiration to millions. Despite facing societal disapproval, financial hurdles, and self-doubt, she has persevered to achieve her dreams. “I was always fascinated by cars and speed,” Humaira recalls. “But growing up in a conservative Muslim family, pursuing racing seemed impossible.”

However, Humaira’s determination and passion for racing led her to balance medical school with part-time jobs and sponsorships to fund her racing career. “It was a mental tug-of-war,” she confesses. “But I didn’t want to give up on either dream.” Her hard work paid off when she was selected to compete in the British Endurance Championship, a first for an Indian female racer.

Humaira’s entry into the championship marked a historic milestone for Indian motorsports. Facing doubts from male teammates and sponsors, she silenced critics with her impressive performance. “I had to prove myself every time I got behind the wheel,” she says. “But I reminded myself that I’d earned my place there.”

As India’s first female racer on the global stage, Humaira inspires countless young girls and women to challenge conventional norms. Her story serves as a powerful reminder that passion and hard work can overcome even the most daunting obstacles. “I want to show girls that they can pursue their dreams, no matter how impossible they seem,” Humaira emphasizes.

Humaira’s remarkable journey has been recognized globally, with several accolades and awards. Her achievements serve as a testament to her unwavering dedication and perseverance. Now preparing for her next race in the GT Championship, Humaira reflects on how her journey serves as an inspiration to young women in India. “Passion, coupled with hard work, has the power to break barriers,” she said.

Hyderabad, October 03, 2024-The three-day G-SPARC 2024, Global South Conference on Infection Prevention, Control, and Antimicrobial Stewardship began on Thursday morning at Shilpakalavedika in Madhapur in the city.

Speaking on the Management of outbreaks and health crises- a politician’s perspective, Ms. Shailaja Teacher, Former Health Minister of Kerala said Infection Prevention and Control, AMR (Anti Microbial Resistance) are global issues. AMR is a silent pandemic she said. AMR is recognized as a global health security threat by WHO (World Health Organisation), CDC(Centre for Disease Control), and UN(United Nations). UN addressed AMR as early as 2016. She gave insights into the preparedness before COVID spread and how proactive measures about AMR, its ‘ policy were taken in Kerala, etc and the introduction of the AMR action plan, the first time India proved to be very effective.

Speaking further she said we need one health approach to address AMR. The estimated global cost it is $ 1000 trillion by 2050.

Kerala became the first state in India to release a sub-national Actional Plan called KARSAP in 2018 and it is conceptualized and implemented on a One Health Platform. We launched the Antibiotic Literate Kerala Campaign in 2019 to make all citizens of Kerala aware of the judicious use of antibiotics in all sectors. We have also launched an AI-based Antibiogram App, she said.

Participating in a panel discussion on the Leadership role in IPC & AMS policy and practices, Dr. Evita Fernandez- Chair of the Fernandez Foundation said nurses are true custodians of the patients. However, they are scared to raise issues when the patient’s health is compromised. When anyone including doctors touches the patient, they need to be sanitized well. Nurses must get their respect. They are not subordinates to doctors. They are our colleagues. Nurses play a big role in stopping infections spread to patients. Doctors must change their attitudes towards nurses and give mutual respect, she added.

Dr Anuj Sharma of the WHO Country Office of India said for an effective AMR plan and its implementation we need a state government’s concurrence on IPC (Infection, Prevention, and Control) and AMR

The panel discussion was moderated by Dr.Hari Prasad-Chaiman – CARE Group of hospitals

The panelists were Dr. Evita Fernandez- Chair, Fernandez Foundation Dr.Gurunath Reddy-Chairman – Continental Hospital; Dr.Vincy Tribhuvan -VP- Of nursing, CARE Group; Dr. Giridhar Gyani -DG- AHPI; Dr. Kashipa Harit- Deputy Director NABH; Dr. Anuj Sharma-Team Focal Point – AMR | IPC, World Health Organization, Country O ce for India

Earlier the meeting began with a session on Understanding the science of complexity and its applications in IPC by Prof. Dr. Vijay V.Yeldandi, Clinical Professor of Medicine and Surgery, University of Illinois, Chicago, USA.

Another session by Dr Annie Thakore, CEO, of Pranaam Hospital Enhancing Infection Control Practices in Hospital Settings followed it.

A panel discussion on the Role of Environmental surveillance in mitigating infectious diseases and antimicrobial resistance was held. The Panelists were Dr. Rakesh Mishra, Director, Tata Institute of Genetics and Society (TIGS), Bengaluru and Principal Investigator, Alliance for Pathogen Surveillance Innovations (APSI)-India; Dr. Vinay K. Nandicoori, Director, CSIR-Centre for Cellular and Molecular Biology (CCMB), Hyderabad and Principal Investigator, APSI-India; Dr. Aruna Panda, Program Director, APSI-India, CCMB, Hyderabad; Dr. Shivranjani C. Moharir, Senior Scientist, TIGS; Dr. Mahesh Dharne, Senior Principal Scientist, CSIR-National Chemical Laboratory, Pune

Some of the prominent speakers who participated in the conference include Dr Anuj Sharma, WHO India Office; Prof Chedly Azzouz, Chairperson, Infection Control Africa Network; Prof. (Dr.) Atul Goel, DGHS & Director, National Centre for Disease Control (NCDC); Ms Shailaja Teacher, MLA and Former-Health Minister, Govt of Kerala

The objective of the conference is to provide a platform for Infection Prevention and Control (IPC), Antimicrobial Resistance (AMR), and Patient Safety stakeholders from Global South (resource-limited countries in Asia, Africa, Middle East, South America) to collaborate for better policies, research, tailored solutions and practices on IPC, AMS and WASH (Water, Sanitation, and Hygiene) and pandemic preparedness.

KEY HIGHLIGHTS (Q2FY24)

• Net Profit increased by 62% YoY to Rs.1,870 Cr.
• Operating Profit stood at Rs.3,004 Cr for Q3FY24 against Rs.3,652 Cr in Q3FY23 and Rs.3,756 Cr in Q2FY24.
• Net Interest Income (NII) stood at Rs.5,463 Cr for Q3FY24 against Rs.5,595 Cr for Q3FY23 and Rs.5,740 Cr in Q2FY24.
• Yield on Advances (Dom.) improved by 53 bps YoY.    Gross NPA ratio down by 231 bps YoY.
• Net NPA ratio down by 20 bps YoY.
• Provision Coverage Ratio (PCR) at 89.95%.
• CRAR stood at 16.06%, with CET-1 ratio at 13.16%.
• Global Business increased by 9.60% YoY.
• Global Deposits increased by 8.28% YoY.
• Global Advances increased by 11.29% YoY.
• RAM Advances grew by 13.61% YoY and it constitutes 55.24% of Advances
• Agriculture Credit grew by 14.23% YoY. MSME Credit grew by 10.61% YoY.

• CASA deposits increased by 5.92% YoY and CASA ratio at 43.88%.

Profitability:

Q3-FY24: 

• Net Profit for the quarter improved by 62% YoY and stood at Rs.1,870 Cr for Q3FY24 against Rs.1,151 Cr in Q3FY23. On a sequential basis, Net Profit improved by 28% from Rs.1,458 Cr in Q2FY24.
• Operating Profit stood at Rs.3,004 Cr for Q3FY24 against Rs.3,652 Cr in Q3FY23 and Rs.3,756 Cr in Q2FY24.
• Net Interest Income (NII) stood at Rs.5,463 Cr for Q3FY24 against Rs.5,595 Cr for Q3FY23 and Rs.5,740 Cr in Q2FY24.
• Non-Interest Income stood at to Rs.1,193 Cr for Q3FY24 against Rs.1,432 Cr in Q3FY23 and Rs.1,688 Cr in Q2FY24.

9Months ended FY24:

• Net Profit increased by 83% YoY and stood at Rs.4,879 Cr for 9 month ended FY’24 against Rs.2,672 Cr in the corresponding period of last year.
• Operating Profit improved by 14% YoY and stood at Rs.10,511 Cr for 9-month ended FY’24 against Rs.9,209 Cr in the corresponding period of last year.
• Net Interest Income (NII) increased by 16% YoY and stood at Rs.17,117 Cr for 9-month ended FY’24 against Rs.14,751 Cr in the corresponding period of last year.
• Non-Interest Income increased by 9% YoY and stood at Rs.4,344 Cr for 9- month ended FY’24 against Rs.4,001 Cr in the corresponding period of last year.

Ratios (Q3-FY24):

• NIM (Global) stood at 2.85% in Q3FY24 against 3.28% in Q3FY23 and 3.08% in Q2FY24.
• NIM (Domestic) stood at 3.21% in Q3FY24 against 3.72% in Q3FY23 and 3.47% in Q2FY24.
• Return on Assets (Global) improved by 27 bps YoY to 0.82% in Q3FY24 against 0.55% in Q3FY23. On a sequential basis it improved by 15 bps from 0.67% in Q2FY24.
• Cost to Income ratio (Global) stood at 54.87% in Q3FY24 against 48.03% in Q3FY23 and 49.44% in Q2FY24.
• Yield on Advances (Global) improved by 70 bps YoY to 8.37% in Q3FY24 against 7.67% in Q3FY23 and 8.54% in Q2FY24.
• Cost of Deposits (Global) stood at 4.62% in Q3FY24 against 3.72% in Q3FY23 and 4.49% in Q2FY24.

Ratios (9Months ended-FY24):

• NIM (Global) improved by 2 bps YoY to 2.98% in 9M-FY24 against 2.96% in 9M-FY23.
• NIM (Domestic) stood at 3.35% in 9M-FY24 against 3.37% in 9M-FY23.
• Return on Assets (RoA) improved by 28 bps YoY to 0.72% in 9M-FY24 against 0.44% in 9M-FY23.
• Return on Equity (RoE) improved by 434 bps YoY to 13.75% in 9M-FY24 against 9.41% in 9M-FY23.
• Cost to Income ratio (Global) stood at 51.02% in 9M-FY24 against 50.89% in 9M-FY23.
• Credit Cost improved by 37 bps to 0.54% 9-Months ended 31 st Dec. 2023
• Yield on Advances (Global) improved by 117 bps to 8.34% in 9M-FY24 against 7.17% in 9M-FY23.
• Cost of Deposits (Global) stood at 4.44% in 9M-FY24 against 3.58% in 9MFY23.

Business:

• Global Business increased by 9.60% YoY from Rs.11,61,441 Cr in Dec’22 to Rs.12,72,887 Cr in Dec’23. (YTD Growth: 7.38%)
• Global Deposits increased by 8.28% YoY from Rs. 6,53,691 Cr in Dec’22 to Rs. 7,07,827 Cr in Dec’23. (YTD Growth: 5.71%)
• Global Advances increased by 11.29% YoY from Rs. 5,07,750 Cr in Dec’22 to Rs. 5,65,060 Cr in Dec’23. (YTD Growth: 9.54%)
• Overseas Deposits increased by 12.07% YOY to Rs. 1,08,690 Cr and Overseas Advances increased by 10.99% YOY to Rs. 90,047 Cr in Dec’23.
• Domestic Deposits increased by 7.62% YoY from Rs.5,56,707 Cr in Dec’22 to Rs.5,99,137 Cr in Dec’23. (YTD Growth: 5.66%)
• Domestic CASA went up by 5.92% YoY from Rs.2,46,718 Cr in Dec’22 to Rs.2,61,335 Cr in Dec’23 and CASA ratio stood at 43.88%. (YTD Growth of CASA Deposits: 3.64%)
• Domestic Advances increased by 11.34% YoY from Rs. 4,26,622 Cr in Dec’22 to Rs. 4,75,012 Cr in Dec’23. (YTD Growth: 10.05%)
• RAM Advances increased by 13.61% YoY to Rs.2,62,390 Cr, constituting to 55.24% of Advances in Dec’23. (YTD Growth: 10.30%)
• Retail Credit grew by 15.40% YoY to Rs.1,05,445 Cr in Dec’23. (YTD Growth: 11.33%)
• Agriculture Credit grew by 14.23% YoY to Rs.80,345 Cr in Dec’23. (YTD Growth: 10.99%)
• MSME Credit grew by 10.61% YoY to Rs.76,600 Cr in Dec’23. (YTD Growth: – 8.23%).

Asset Quality:

• Gross NPA declined by 22.24% YoY from Rs.38,885 Cr in Dec’22 to Rs.30,237 Cr in Dec’23.
• Net NPA declined by 0.25% YoY from Rs.7,646 Cr in Dec’22 to Rs.7,627 Cr in Dec’23.
• GNPA ratio improved by 231 bps from 7.66% in Dec’22 to 5.35% in Dec’23.
• Net NPA ratio improved by 20 bps from 1.61% in Dec’22 to 1.41% in Dec’23.
• Provision Coverage Ratio (PCR) stood at 89.95% in Dec’23 against 90.27% in Dec’22.

Capital Adequacy:

• As on 31.12.2023, Bank’s total Capital Adequacy Ratio (CRAR) was at 16.06% against 15.60% in Dec’22.
• CET-1 ratio stood at 13.16% as on Dec’23.

Priority Sector:

• Priority Sector Advances increased by 10.51% YOY and achieved 43.62% of ANBC as on Dec’23. Agricultural advances achieved 19.72% of ANBC.
• Advances to Small & Marginal Farmers achieved 12.68% of ANBC in Dec’23 against regulatory norm of 10%.
• Advances to Weaker Sections achieved 15.82% of ANBC in Dec’23 against regulatory norm of 12%

Financial Inclusion:

Digital Banking:

• Internet Banking users: Increased to 8.8 million in Dec’23 from 8.4 million in
• Dec’22.
• Mobile Banking users: Increased to 10.1 million in Dec’23 from 7.1 million in
• Dec’22.
• Number of UPI users increased to 18.0 million in Dec’23 from 14.8 million in
• Dec’22.

Branch Network:

• As on 31st Dec’23, the Bank has 5139 number of Domestic branches.
• Rural: 1861 (36%), Semi-Urban: 1457 (28%), Urban: 831 (16%), Metro: 990 (19%).